RP
Robert Paull
Co-Founder and Venture Partner·Lux Capital
Robert Paull is Co-Founder and Venture Partner at Lux Capital, focused on healthcare. He manages Lux investments in Cala Health, Kala Pharmaceuticals, Kyruus, and Visterra, and his previous investments include Cerulean Pharmaceuticals, Magen Biosciences, and Molecular Imprints. He was founding CEO of Harvard Medical School spinout Genocea Biosciences and Johns Hopkins spinout Kala Pharmaceuticals, and he co-founded Lux Research.
See the rest of Robert Paull's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.